The hypothesis that early MBD, marked by increased plasma concentrations of FGF-23,would influence the atherosclerosis process in patients with primaryglomerulonephritis was not confirmed in our evaluation, which wascross-sectional. This evidence concerns the gene FGF23 and atherosclerosis.